Sirnaomics Ltd. (HKG:2257)

Market Cap	644.68M +101.9%
Revenue (ttm)	n/a
Net Income	-112.10M
EPS	-1.19
Shares Out	108.90M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	565,950
Open	5.99
Previous Close	5.92
Day's Range	5.12 - 6.12
52-Week Range	3.50 - 22.78
Beta	-0.03
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 4, 2026

About Sirnaomics

Sirnaomics Ltd., an RNA therapeutics biopharmaceutical company, discovers and develops drugs for indications with medical needs in the People’s Republic of China. The company’s therapeutics products focus on oncology and fibrosis, anticoagulant therapies, cardiometabolic disease, complement-mediated diseases, medical aesthetics, and viral infections. Its lead drug candidates comprising STP705 for the treatment of non-melanoma skin cancer and for focal fat reduction; STP369 to treat head and neck cancer; and STP707 and STP355 to treat solid tumo...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 37
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2257

Financial Performance

Financial numbers in USD